Survival in primary pulmonary hypertension. Validation of a prognostic equation
- PMID: 8149539
- DOI: 10.1161/01.cir.89.4.1733
Survival in primary pulmonary hypertension. Validation of a prognostic equation
Abstract
Background: The prognosis of patients with primary pulmonary hypertension (PPH) remains a major problem for the planning and assessment of therapeutic interventions. The objectives of this study were (1) to characterize mortality in a Mexican population of patients with PPH and to investigate factors associated with survival and (2) to test the applicability in this population of the prognostic equation proposed by the US National Institutes of Health study on PPH.
Methods and results: A dynamic cohort of patients with PPH at our institution were enrolled between June 1977 and August 1991 and prospectively followed at regular intervals through September 1992. Measurements at diagnosis included hemodynamic and pulmonary function variables in addition to information on demographic data and medical history. The response to vasodilator treatment was also analyzed. The estimated median survival of the group was 4.04 years (95% confidence interval, 2.98 to 5.08 years). Variables associated with poor survival (univariate analysis) included an elevated mean right atrial pressure, a decreased cardiac index, and a decreased mixed venous PO2. A reduced forced vital capacity and the absence of vasodilator treatment were also associated with poor survival. A multivariate Cox proportional-hazards regression analysis was used to assess the adjusted hazard ratios, hence the relative contributions of the variables controlling for confounding. Reduced forced vital capacity and cardiac index and increased right atrial pressure were still significantly associated as risk factors for survival in patients with PPH. Survival as computed by the equation correlated with real survival of PPH patients with positive predictive values of 87%, 91%, and 89% at 1, 2, and 3 years, respectively. The equation, however, was relatively unable to predict deaths in our population, in part because of the strict limits of poor prognosis.
Conclusions: Mortality in PPH is largely associated with hemodynamic variables that assess right ventricular function. The proposed prognostic equation had a high sensitivity and a relatively low specificity to predict survival in our PPH population. To improve this specificity it may be necessary to increase the limits of poor prognosis as defined by the equation.
Similar articles
-
Primary pulmonary hypertension in children: clinical characterization and survival.J Am Coll Cardiol. 1995 Feb;25(2):466-74. doi: 10.1016/0735-1097(94)00391-3. J Am Coll Cardiol. 1995. PMID: 7829802
-
[Primary or of unknown etiology pulmonary hypertension: survival and its determinants].Gac Med Mex. 1994 Nov-Dec;130(6):465-75. Gac Med Mex. 1994. PMID: 7557062 Spanish.
-
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.Am Heart J. 2003 Feb;145(2):310-6. doi: 10.1067/mhj.2003.146. Am Heart J. 2003. PMID: 12595849
-
[Therapeutic management of primary pulmonary hypertension].Presse Med. 2002 Feb 23;31(7):320-8. Presse Med. 2002. PMID: 11899690 Review. French.
-
Primary pulmonary hypertension.Lancet. 1998 Aug 29;352(9129):719-25. doi: 10.1016/S0140-6736(98)02111-4. Lancet. 1998. PMID: 9729004 Review.
Cited by
-
Regional right ventricular wall motion in tetralogy of fallot: a three dimensional analysis.Int J Cardiovasc Imaging. 2013 Jun;29(5):1051-8. doi: 10.1007/s10554-012-0178-2. Epub 2013 Jan 6. Int J Cardiovasc Imaging. 2013. PMID: 23292150
-
Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.Circ Heart Fail. 2013 Jan;6(1):136-44. doi: 10.1161/CIRCHEARTFAILURE.111.966127. Epub 2012 Nov 14. Circ Heart Fail. 2013. PMID: 23152488 Free PMC article.
-
Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?BMC Cardiovasc Disord. 2010 Feb 22;10:9. doi: 10.1186/1471-2261-10-9. BMC Cardiovasc Disord. 2010. PMID: 20170553 Free PMC article.
-
Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome.Int J Cardiovasc Imaging. 2007 Apr;23(2):209-15. doi: 10.1007/s10554-006-9140-5. Epub 2006 Sep 14. Int J Cardiovasc Imaging. 2007. PMID: 16972146
-
Analysis of pulmonary hypertension patient survival after treatment in referral center (data of first Ukrainian register).Pulm Circ. 2019 Apr-Jun;9(2):2045894019845604. doi: 10.1177/2045894019845604. Pulm Circ. 2019. PMID: 30942126 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical